Implantation of the Jarvik 2000® left ventricular assist device using the miniaturized extracorporeal circulation system - A case report

Francesco Formica, Oluwaseun Adebayo Bamodu, Serena Mariani, Rosa Caruso, Fabio Sangalli, Giovanni Paolini

Research output: Contribution to journalArticle

Abstract

Myocardial failure is generally considered to be a progressive, irreversible medical condition with characteristic ventricular enlargement, spatial alteration of the heart chambers, diminished cardiac inotropy and resultant dysfunctional, mechanically inefficient heart. The Jarvik 2000®, similar to the mechanical pump, is an electrically powered, axial-flow left ventricular assist device (LVAD) designed to enhance the function of the chronically failing heart and, consequently, normalize the cardiac output for a long period of time. We report the case of 70-year-old man with congestive dilated cardiomyopathy and bioprosthetic mitral valve who underwent surgical implantation of the Jarvik 2000® LVAD, using the miniaturized extracorporeal circulation (MECC) system. The LVAD was implanted through a left thoracotomy and the MECC system was used to avoid intraoperative spontaneous hemodynamic instability and/or malignant ventricular arrhythmia. The circulatory support with the MECC system was optimal and no complication in terms of hemodynamic instability and perioperative bleeding was recorded. The MECC system obliterated the adverse effects associated with conventional extracorporeal circulation, which are often fatal in critically-ill patients.

Original languageEnglish
Pages (from-to)518-520
Number of pages3
JournalPerfusion
Volume31
Issue number6
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Left ventricular assist devices
Heart-Assist Devices
Extracorporeal Circulation
Hemodynamics
Dilated Cardiomyopathy
Optimal systems
Axial flow
chamber
Pumps
Thoracotomy
Mitral Valve
Critical Illness
Cardiac Output
Cardiac Arrhythmias
Heart Failure
Hemorrhage

Keywords

  • congestive heart failure
  • Jarvik
  • LVAD
  • miniaturized extracorporeal circulation
  • sternotomy
  • thoracotomy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Safety Research
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialised Nursing

Cite this

Implantation of the Jarvik 2000® left ventricular assist device using the miniaturized extracorporeal circulation system - A case report. / Formica, Francesco; Bamodu, Oluwaseun Adebayo; Mariani, Serena; Caruso, Rosa; Sangalli, Fabio; Paolini, Giovanni.

In: Perfusion, Vol. 31, No. 6, 01.09.2016, p. 518-520.

Research output: Contribution to journalArticle

Formica, Francesco ; Bamodu, Oluwaseun Adebayo ; Mariani, Serena ; Caruso, Rosa ; Sangalli, Fabio ; Paolini, Giovanni. / Implantation of the Jarvik 2000® left ventricular assist device using the miniaturized extracorporeal circulation system - A case report. In: Perfusion. 2016 ; Vol. 31, No. 6. pp. 518-520.
@article{44663b8f4b2b4e4dab14e313d40ad1d3,
title = "Implantation of the Jarvik 2000{\circledR} left ventricular assist device using the miniaturized extracorporeal circulation system - A case report",
abstract = "Myocardial failure is generally considered to be a progressive, irreversible medical condition with characteristic ventricular enlargement, spatial alteration of the heart chambers, diminished cardiac inotropy and resultant dysfunctional, mechanically inefficient heart. The Jarvik 2000{\circledR}, similar to the mechanical pump, is an electrically powered, axial-flow left ventricular assist device (LVAD) designed to enhance the function of the chronically failing heart and, consequently, normalize the cardiac output for a long period of time. We report the case of 70-year-old man with congestive dilated cardiomyopathy and bioprosthetic mitral valve who underwent surgical implantation of the Jarvik 2000{\circledR} LVAD, using the miniaturized extracorporeal circulation (MECC) system. The LVAD was implanted through a left thoracotomy and the MECC system was used to avoid intraoperative spontaneous hemodynamic instability and/or malignant ventricular arrhythmia. The circulatory support with the MECC system was optimal and no complication in terms of hemodynamic instability and perioperative bleeding was recorded. The MECC system obliterated the adverse effects associated with conventional extracorporeal circulation, which are often fatal in critically-ill patients.",
keywords = "congestive heart failure, Jarvik, LVAD, miniaturized extracorporeal circulation, sternotomy, thoracotomy",
author = "Francesco Formica and Bamodu, {Oluwaseun Adebayo} and Serena Mariani and Rosa Caruso and Fabio Sangalli and Giovanni Paolini",
year = "2016",
month = "9",
day = "1",
doi = "10.1177/0267659115627692",
language = "English",
volume = "31",
pages = "518--520",
journal = "Perfusion (United Kingdom)",
issn = "0267-6591",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Implantation of the Jarvik 2000® left ventricular assist device using the miniaturized extracorporeal circulation system - A case report

AU - Formica, Francesco

AU - Bamodu, Oluwaseun Adebayo

AU - Mariani, Serena

AU - Caruso, Rosa

AU - Sangalli, Fabio

AU - Paolini, Giovanni

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Myocardial failure is generally considered to be a progressive, irreversible medical condition with characteristic ventricular enlargement, spatial alteration of the heart chambers, diminished cardiac inotropy and resultant dysfunctional, mechanically inefficient heart. The Jarvik 2000®, similar to the mechanical pump, is an electrically powered, axial-flow left ventricular assist device (LVAD) designed to enhance the function of the chronically failing heart and, consequently, normalize the cardiac output for a long period of time. We report the case of 70-year-old man with congestive dilated cardiomyopathy and bioprosthetic mitral valve who underwent surgical implantation of the Jarvik 2000® LVAD, using the miniaturized extracorporeal circulation (MECC) system. The LVAD was implanted through a left thoracotomy and the MECC system was used to avoid intraoperative spontaneous hemodynamic instability and/or malignant ventricular arrhythmia. The circulatory support with the MECC system was optimal and no complication in terms of hemodynamic instability and perioperative bleeding was recorded. The MECC system obliterated the adverse effects associated with conventional extracorporeal circulation, which are often fatal in critically-ill patients.

AB - Myocardial failure is generally considered to be a progressive, irreversible medical condition with characteristic ventricular enlargement, spatial alteration of the heart chambers, diminished cardiac inotropy and resultant dysfunctional, mechanically inefficient heart. The Jarvik 2000®, similar to the mechanical pump, is an electrically powered, axial-flow left ventricular assist device (LVAD) designed to enhance the function of the chronically failing heart and, consequently, normalize the cardiac output for a long period of time. We report the case of 70-year-old man with congestive dilated cardiomyopathy and bioprosthetic mitral valve who underwent surgical implantation of the Jarvik 2000® LVAD, using the miniaturized extracorporeal circulation (MECC) system. The LVAD was implanted through a left thoracotomy and the MECC system was used to avoid intraoperative spontaneous hemodynamic instability and/or malignant ventricular arrhythmia. The circulatory support with the MECC system was optimal and no complication in terms of hemodynamic instability and perioperative bleeding was recorded. The MECC system obliterated the adverse effects associated with conventional extracorporeal circulation, which are often fatal in critically-ill patients.

KW - congestive heart failure

KW - Jarvik

KW - LVAD

KW - miniaturized extracorporeal circulation

KW - sternotomy

KW - thoracotomy

UR - http://www.scopus.com/inward/record.url?scp=84984868398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984868398&partnerID=8YFLogxK

U2 - 10.1177/0267659115627692

DO - 10.1177/0267659115627692

M3 - Article

C2 - 26791274

AN - SCOPUS:84984868398

VL - 31

SP - 518

EP - 520

JO - Perfusion (United Kingdom)

JF - Perfusion (United Kingdom)

SN - 0267-6591

IS - 6

ER -